IRS2 and Hepatitis: After inhibiting miR-34a in a high-fat-induced hepatic IR model, the expression of p-IRS2 (Ser1100) was significantly downregulated, while its downstream p-Akt (Ser473) expression was significantly increased, leading to impaired glucose metabolism-related indices.